Skip to content
Disclosery

Ergoteles LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Ergoteles LLC on GSK, newest first. How the timeline and the estimate are built.

Ergoteles LLC held 0 GSK shares at 2023-03-31 per its 13F-HR filed 2023-05-10.

the latest 13F is the newest step

  1. period ended2023-03-31
    13F 0 shares
    Change vs previous 13F -12,617 shares

    13F-HR 0001569136-23-000002 filed by Ergoteles LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2022-12-31
    13F 12,617 shares
    Change vs previous 13F -41,051 shares

    0.02% of the 13F portfolio, value $443,361.

    13F-HR 0001569136-23-000001 filed by Ergoteles LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2022-09-30
    13F 53,668 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $1,579,000.

    13F-HR 0001569136-22-000007 filed by Ergoteles LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).